Mencoboni, M.; Fontana, V.; Damiani, A.; Spitaleri, A.; Raso, A.; Bottaro, L.C.; Rossi, G.; Canobbio, L.; La Camera, A.; Filiberti, R.A.;
et al. Antibody Response to COVID-19 mRNA Vaccines in Oncologic and Hematologic Patients Undergoing Chemotherapy. Curr. Oncol. 2022, 29, 3364-3374.
https://doi.org/10.3390/curroncol29050273
AMA Style
Mencoboni M, Fontana V, Damiani A, Spitaleri A, Raso A, Bottaro LC, Rossi G, Canobbio L, La Camera A, Filiberti RA,
et al. Antibody Response to COVID-19 mRNA Vaccines in Oncologic and Hematologic Patients Undergoing Chemotherapy. Current Oncology. 2022; 29(5):3364-3374.
https://doi.org/10.3390/curroncol29050273
Chicago/Turabian Style
Mencoboni, Manlio, Vincenzo Fontana, Azzurra Damiani, Antonino Spitaleri, Alessandro Raso, Luigi Carlo Bottaro, Giovanni Rossi, Luciano Canobbio, Antonella La Camera, Rosa Angela Filiberti,
and et al. 2022. "Antibody Response to COVID-19 mRNA Vaccines in Oncologic and Hematologic Patients Undergoing Chemotherapy" Current Oncology 29, no. 5: 3364-3374.
https://doi.org/10.3390/curroncol29050273
APA Style
Mencoboni, M., Fontana, V., Damiani, A., Spitaleri, A., Raso, A., Bottaro, L. C., Rossi, G., Canobbio, L., La Camera, A., Filiberti, R. A., Taveggia, P., & Cavo, A.
(2022). Antibody Response to COVID-19 mRNA Vaccines in Oncologic and Hematologic Patients Undergoing Chemotherapy. Current Oncology, 29(5), 3364-3374.
https://doi.org/10.3390/curroncol29050273
